Scienza e Tecnologia

SecurityHQ Release New Mobile App

Backed by the power of SecurityHQ's leading Global Security Operation Centres on your mobile device, the new app has significantly advanced the accessibility and visibility of SecurityHQ services and provides a considerable competitive advantage in terms of customer experience and engagement. Backed by the power of SecurityHQ's leading Global Security Operation Centres on your mobile device, the new app has significantly advanced the accessibility and visibility of SecurityHQ services and...
PR Newswire
23/02/2021

Securitas acquires leading fire and safety company in Denmark

Peter Karlströmer, Divisional President Security Services Europe: "We are very happy to welcome Dansk Brandteknik's team to Securitas and are looking forward to working together. Dansk Brandteknik is one of the strongest players in their space selling products and services as a solutions offering, fitting perfectly with Securitas' strategy of providing protective services bundled as security solutions. We can now package fire technology and consulting with our broader product portfolio…
PR Newswire
22/02/2021

Gene Therapy Cell Culture Media Market to Reach $278.96 Mn, Globally, by 2027 at…

Download Sample Report (Detailed COVID-19 Impact) at: https://www.alliedmarketresearch.com/request-sample/9430 Download Sample Report (Detailed COVID-19 Impact) at: https://www.alliedmarketresearch.com/request-sample/9430 Prime determinants of growth Rise in R&D investments, surge in awareness regarding gene therapy, advancements related to gene therapy, and increase in prevalence of cancer drive the growth of the global gene therapy cell culture media market. However, scarcity...
PR Newswire
22/02/2021

BioVaxys Announces Appointment To Its Scientific Advisory Board

Dr. Chandran is a professor of microbiology and immunology and the Harold and Muriel Block Scholar in Virology at Albert Einstein College of Medicine in New York City, where he oversees a team of researchers engaged in basic and translational research on emerging RNA viruses and investigating the molecular mechanisms of infection. Dr. Chandran's laboratory focuses on coronaviruses and filoviruses, including SARS-CoV-2, Ebola virus, and Marburg virus, and other neglected emerging viruses such as…
PR Newswire
22/02/2021

The Lithium Boom Is Only Just Getting Started

It's expected to change the landscape of our cities… What vehicles we buy… And how we travel throughout the day. That's why Tesla has built a 1.9 million square foot factory to ramp up production of the lithium-ion batteries for their electric vehicles…With plans to produce batteries for over 500,000 vehicles per year. It's expected to change the landscape of our cities… What vehicles we buy… And how we travel throughout the day. That's why Tesla has built a 1.9 million square foot factory ...
PR Newswire
22/02/2021

Benzenoid Market worth $857 million by 2025 - Exclusive Report by…

The spread of COVID-19 pandemic affected the overall chemicals market in the global regions. The value of trade in organic chemicals reached USD 846 billion in 2019, which decreased by nearly 10% from 2018 in terms of value. The economy of China was also affected by events such as the Chinese economic slowdown & US-China trade wars. As reported by the Financial Express in May 2020, the country recorded low oil prices in 2020 and has impacted the chemicals and petrochemicals industries. The…
PR Newswire
22/02/2021

Anticoagulant Reversal Drugs Market Size Worth $1.81 Billion By 2027: Grand View…

Read 110 page research report with ToC on "Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine), By Distribution Channel, And Segment Forecasts, 2020 - 2027" at:https://www.grandviewresearch.com/industry-analysis/anticoagulant-reversal-drugs-market Read 110 page research report with ToC on "Anticoagulant Reversal Drugs Market Size, Share & Trends…
PR Newswire
22/02/2021

SunRock Biopharma and GenScript ProBio Enter into a Collaboration Agreement to…

CCR9 is a novel therapeutic target expressed in highly aggressive cancer. It is associated with increased metastatic potential and tumor-chemoresistance. This program will enable new treatment formats with innovative monoclonal antibody drugs of different blood neoplasia and solid tumors with a highly unmet clinical need, such as T-cell acute lymphoblastic leukemia or pancreatic cancer. CCR9 is a novel therapeutic target expressed in highly aggressive cancer. It is associated with increased...
PR Newswire
22/02/2021

EZVIZ unveils the C8C, its first-ever outdoor pan/tilt Wi-Fi camera, taking a…

LOS ANGELES, Feb. 22, 2021 /PRNewswire/ -- EZVIZ, a global innovator in home intelligence, has strengthened its product offerings with its first outdoor pan/tilt camera C8C. Designed to overcome challenges in outdoor surveillance and protection, the C8C boasts powerful features including panoramic monitoring, AI-powered human shape detection, color night vision, and event-triggered active defense. It is an all-in-one camera that records, detects, and deters effectively in the face of property…
PR Newswire
22/02/2021

EZVIZ unveils the C8C, its first-ever outdoor pan/tilt Wi-Fi camera, taking a…

LOS ANGELES, Feb. 22, 2021 /PRNewswire/ -- EZVIZ, a global innovator in home intelligence, has strengthened its product offerings with its first outdoor pan/tilt camera C8C. Designed to overcome challenges in outdoor surveillance and protection, the C8C boasts powerful features including panoramic monitoring, AI-powered human shape detection, color night vision, and event-triggered active defense. It is an all-in-one camera that records, detects, and deters effectively in the face of property…
PR Newswire
21/02/2021

Dynavax Announces European Commission Marketing Authorization for HEPLISAV B®, a…

-- Statistically significantly higher and faster rates of protection and similar safety compared to Engerix-B in all 3 trials -- Statistically significantly higher and faster rates of protection and similar safety compared to Engerix-B in all 3 trials -- HEPLISAV B is the only 2-dose adult hepatitis B vaccine offering protection in just 1 month EMERYVILLE, Calif.,Feb. 19, 2021/PRNewswire/ -- Dynavax Technologies Corporation(Nasdaq: DVAX), a biopharmaceutical company focused on...
PR Newswire
19/02/2021

Incap Corporation: Incap increases its operating profit estimate for 2020

Incap Corporation Stock Exchange Release 19 February 2021 at 5.00 p.m. (EET)Inside information Incap increases its operating profit estimate for 2020 Incap Corporation estimates that its revenue for 2020 will be approximately EUR 106.5 million and the operating profit (EBIT) approximately EUR 12.6 million. Previously the company estimated that its revenue for 2020 will be approximately EUR 105–107 million and the operating profit (EBIT)...
Nasdaq GlobeNewswire
19/02/2021

YEAR-END REPORT 2020

POSITIVE ACHIEVEMENTS IN DIFFICULT TIMES FOURTH QUARTER 2020Net sales totalled MSEK 13.9 (14.8), a decrease of MSEK 0.9 / 6 %EBITDA was MSEK 0.3 (-9.4), an increase of MSEK 9.7Operating profit/loss was MSEK -1.5 (-11.2), an increase of MSEK 9.7Profit/loss after tax was MSEK -6.3 (-10.4), an increase of MSEK 4.1Earnings per share amounted to SEK -0.19 (-0.31)JANUARY – DECEMBER 2020Net sales totalled MSEK 52.8 (58.6), a decrease of MSEK 5.8 / 10 %EBITDA was MSEK -4.9 (-20...
Nasdaq GlobeNewswire
19/02/2021

Notification of major shareholding

Company Announcement 19 February 2021 Announcement No. 1 Notification of major shareholdingWith reference to Section 30 of the Danish Capital Market Act, NKT A/S has been informed that Greenvale Capital LLP has acquired shares in NKT A/S resulting in the 5% threshold to be passed.Greenvale Capital LLP's total shareholding has increased to 2,256,443 shares corresponding to 5.25% of the share capital of NKT A/S. Contact Investor Relations: Michael Nass Nielsen, Head of Investor...
Nasdaq GlobeNewswire
19/02/2021

Nexans Notice of Early Full Redemption of EUR 250,000,000 Senior Unsecured Fixed…

NEXANS NOTICE OF EARLY FULL REDEMPTION OF EUR 250,000,000 SENIOR UNSECURED FIXED RATE BONDS DUE 2021 NEXANSSociété anonymewith a share capital of EUR 44,105,941Registered office: 4 allée de l'Arche, 92400 Courbevoie RCS Nanterre 393 525 852(the “ Issuer ”)___________________________ NOTICE OF FULL REDEMPTIONIN RESPECT OF THE EUR 250,000,000 3.25 PER CENT. NOTES ISSUED ON MAY 26, 2016 AND DUE ON MAY 26, 2021ISIN NO.: FR0013176294 COMMON CODE: 142037009...
Nasdaq GlobeNewswire
18/02/2021

Elkem ASA - Successful placement of senior unsecured NOK bonds

SEB and Swedbank have acted as Joint Lead Managers for the bond issue. SEB and Swedbank have acted as Joint Lead Managers for the bond issue. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further information, please contact: Odd- Geir LyngstadVP Finance and Investor Relations Tel: +47 976 72 806 Email:[email protected] About Elkem Founded in 1904, Elkem is one of the world's leading...
PR Newswire
18/02/2021

Secure Identity Alliance launches Global Identity Report

PARIS, Feb. 18, 2021 /PRNewswire/ -- With digital identity gaining considerable momentum, Secure Identity Alliance today publishes Giving Voice to Digital Identities Worldwide, a new report charting the current state of government-led identity projects across the globe. PARIS,Feb. 18, 2021/PRNewswire/ -- With digital identity gaining considerable momentum, Secure Identity Alliance today publishesGiving Voice to Digital Identities Worldwide, a newreportcharting the current state of...
PR Newswire
18/02/2021

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A…

BioElpida is a biotechnology contract development and manufacturing company ("CDMO") which applies single-use bioprocessing for development and manufacturing of biological and cell-based products. BioElpida's expertise extends from R&D to pharmaceutical manufacturing and release of clinical batches, and intermediate steps such as process development, feasibility studies, analytical method validation, as well as aseptic fill & finish and other bioproduction services. BioElpida's…
PR Newswire
18/02/2021

Nexans: COMPOSITION OF THE BOARD OF DIRECTORS PROPOSALS TO THE 2021…

PRESS RELASE _ COMPOSITION OF THE BOARD OF DIRECTORS PROPOSALS TO THE 2021 SHAREHOLDERS' MEETINGLa Défense, February 18th, 2021- Upon the recommendation of the Appointments and Corporate Governance Committee, Nexans Board of Directors has resolved to propose to the 2021 Shareholders' Meeting to renew, for a period of four years, the terms of office of Andrónico Luksic Craig and Francisco Pérez Mackenna, directors proposed by the main shareholder Invexans Limited, and of Marc Grynberg...
Nasdaq GlobeNewswire
18/02/2021

SkylineDx achieves new milestone with ISO 13485:2016 certification

About SkylineDx About SkylineDx SkylineDx is a biotechnology company, focused on research & development of molecular diagnostics in oncology and inflammatory diseases. The company is headquartered inRotterdam( the Netherlands ) and complemented with a field medical and scientific affairs team in the US and a CAP/CLIA certified laboratory inSan Diego( California ). SkylineDx uses its expertise to bridge the gap between academically discovered gene expression signatures and...
PR Newswire
18/02/2021

Recombinant Growth Factors to Account for Over 45% of Overall Demand through…

According to a latest report published by Persistence Market Research, the global recombinant cell culture supplements market was valued at US$ 441 Mn in 2020, and is predicted to witness an impressive CAGR of over 6% during the forecast period (2021 – 2031). According to a latest report published by Persistence Market Research, the global recombinant cell culture supplements market was valued atUS$ 441 Mnin 2020, and is predicted to witness an impressive CAGR of over 6% during the...
PR Newswire
18/02/2021

Global Cell Therapy Market, Therapies Sales Size Forecast At USD 45 Billion By…

Download Report: https://www.kuickresearch.com/report-global-cell-therapy-therapies-market-report-technologies-drugs-size-sales-growth-forecast--billion-million-car-t-cell--stem-cell-therapies-personalized-therapy-us-usa-market Download Report:https://www.kuickresearch.com/report-global-cell-therapy-therapies-market-report-technologies-drugs-size-sales-growth-forecast--billion-million-car-t-cell--stem-cell-therapies-personalized-therapy-us-usa-market Global pharmaceutical market is highly...
PR Newswire
18/02/2021

Preclinical CRO Market Size Worth $8.4 Billion By 2028 | CAGR: 8.1%: Grand View…

Read 240 page research report with ToC on "Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End-use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2021 - 2028" at:https://www.grandviewresearch.com/industry-analysis/preclinical-cro-market Read 240 page research report with ToC on "Preclinical CRO Market Size, Share & Trends Analysis Report By Service…
PR Newswire
18/02/2021

Enedo Plc's Financial Statements Release 1 January – 31 December 2020

ENEDO PLC Financial Statements Release February 18th, 2021 at 9.45 a.m. Enedo Plc's Financial Statements Release 1 January – 31 December 2020 This release is a summary of Enedo's financial statement report January - December 2020. The full report is a pdf attachment to this stock exchange release and is available at company website atwww.enedopower.com. July – December 2020 in brief, Continuing operations- Net sales EUR 18,8 million (EUR 20,3 million) - Operating profit EUR...
Nasdaq GlobeNewswire
18/02/2021
Altri  Comunicati